Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Belmaker

Showing results (91-100 of 404) with videos related to

Pageof 41
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 1, 2001
The mechanism of lithium action: state of the art, ten years laterA Shaldubina, G Agam, R H Belmaker
The American Journal of Psychiatry|October 1, 1978
Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisiaD Gagrat, J Hamilton, R H Belmaker
Harefuah|July 1, 1979
[Diagnostic problems in manic psychosis]J Biederman, J Lerner, R H Belmaker
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2008
Role of GSK3beta in behavioral abnormalities induced by serotonin deficiencyR H Belmaker, Galila Agam, Yuly Bersudsky
Psychopharmacology. Supplementum|January 1, 1985
Intermittent treatment with droperidol, a short-acting neuroleptic, increases behavioral dopamine receptor sensitivityR H Belmaker, A Elami, J Bannet
The Journal of Clinical Psychiatry|May 14, 2005
Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorderBoris Nemets, Yuly Bersudsky, R H Belmaker
The American Journal of Psychiatry|March 1, 2002
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorderBoris Nemets, Ziva Stahl, R H Belmaker
Advances in Biochemical Psychopharmacology|January 1, 1982
Salbutamol treatment of depressionR H Belmaker, B Lerer, J Zohar
Schizophrenia Research|October 12, 2001
Low GSK-3 activity in frontal cortex of schizophrenic patientsN Kozlovsky, R H Belmaker, G Agam
Journal of Neural Transmission|January 1, 1988
Lack of effectiveness of forskolin or inositol as antidote in lithium toxicity. Short noteZ Kaplan, G Schreiber, R H Belmaker
Pageof 41

Showing results (91-100 of 404) with videos related to

Sort By:
Pageof 41
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 1, 2001
The mechanism of lithium action: state of the art, ten years laterA Shaldubina, G Agam, R H Belmaker
The American Journal of Psychiatry|October 1, 1978
Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisiaD Gagrat, J Hamilton, R H Belmaker
Harefuah|July 1, 1979
[Diagnostic problems in manic psychosis]J Biederman, J Lerner, R H Belmaker
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2008
Role of GSK3beta in behavioral abnormalities induced by serotonin deficiencyR H Belmaker, Galila Agam, Yuly Bersudsky
Psychopharmacology. Supplementum|January 1, 1985
Intermittent treatment with droperidol, a short-acting neuroleptic, increases behavioral dopamine receptor sensitivityR H Belmaker, A Elami, J Bannet
The Journal of Clinical Psychiatry|May 14, 2005
Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorderBoris Nemets, Yuly Bersudsky, R H Belmaker
The American Journal of Psychiatry|March 1, 2002
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorderBoris Nemets, Ziva Stahl, R H Belmaker
Advances in Biochemical Psychopharmacology|January 1, 1982
Salbutamol treatment of depressionR H Belmaker, B Lerer, J Zohar
Schizophrenia Research|October 12, 2001
Low GSK-3 activity in frontal cortex of schizophrenic patientsN Kozlovsky, R H Belmaker, G Agam
Journal of Neural Transmission|January 1, 1988
Lack of effectiveness of forskolin or inositol as antidote in lithium toxicity. Short noteZ Kaplan, G Schreiber, R H Belmaker
Pageof 41